• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-CDCA4

CDCA4 Polyclonal Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, IP, IF, CoIP, ELISA

Conjugaison

Non conjugué

N° de cat : 11625-1-AP

Synonymes

CDCA4, HEPP, SEI 3/HEPP



Applications testées

Résultats positifs en WBcellules HEK-293, cellules HeLa, cellules MCF-7, cellules PC-3

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

11625-1-AP cible CDCA4 dans les applications de WB, IP, IF, CoIP, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène CDCA4 Protéine recombinante Ag2214
Nom complet cell division cycle associated 4
Masse moléculaire calculée 241 aa, 26 kDa
Poids moléculaire observé 33 kDa
Numéro d’acquisition GenBankBC025263
Symbole du gène CDCA4
Identification du gène (NCBI) 55038
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

TRIP-Br proteins are a set of proteins with the potential to function in both transcriptional control and cell cycle regulation [PMID:18572021]. CECA4 is a member of TRIP-br family, based on its homologous sequence motifs including SERTA and a PHD-bromo-binding site which interacts with a series of bromodomain containing transcriptional cofactors[PMID:17141982]. When activated by E2F, CDCA4 consequently functions as a suppressor of E2F-responsive promoters to participate the regulation of cell proliferation through the E2F/pRb pathway [PMID:16098148].

Protocole

Product Specific Protocols
WB protocol for CDCA4 antibody 11625-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
mouseWB

Cancer Cell

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors - Ulf Klein
  • KD Validated
humanIF

Sci Rep

Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.

Authors - Honghai Xia
humanWB,CoIP

Cancer Cell Int

CDCA4 suppresses epithelial-mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy.

Authors - Chenxin Xu
  • KD Validated
humanWB,IP

Thorac Cancer

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway

Authors - Sitong Feng
  • KD Validated
human,mouseWB

Gene

ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4

Authors - Jianlong Tan
  • KD Validated
humanWB

Front Mol Biosci

Construction of shared gene signature between rheumatoid arthritis and lung adenocarcinoma helps to predict the prognosis and tumor microenvironment of the LUAD patients

Authors - Liping Shi